Logo Medical Data Models (MDM) Portal Logo Westfälische Wilhelms-Universität (WWU)
Information:
Error:
en ▾
  • Deutsch
  • English
  • Español
  • Italiano
  • Français
  • Português
  • Svenska
  • Nederlands
  • Login
  • Register
  • Search
  • ODM-XML file upload
  • Create data model
  • ODM-Edit tool
  • Metadata Registry
  • Help
  • About the MDM portal
  • Imprint
  • Login
  • Register

Search through specific fields of a model

The name of the data model contains study:
name:"study"
The description contains two terms:
description:"double blind"
The copyrightholder contains the term UKM:
copyrightholder:"UKM"
The uploader of the model is Martin Dugas:
uploader:"Martin Dugas"
The keywords contain cancer:
keyword:"cancer"

Refine the search with search operators

Search for groups of words with quotes:
"leukemia myeloid"
Use a wildcard to search for prefixes:
NCT*
With AND/OR/NOT find study without eye nor ear:
study AND NOT (eye OR ear)
Cancer must (+) occur, study not (-):
+cancer -study
You may connect the different search techniques:
name:"form*" AND routine
Actions ▾
  • ODM-XML file upload
  • Create data model
  • ODM-Edit tool
  • Metadata Registry
  • About the MDM portal
en ▾
  • Deutsch
  • English
  • Español
  • Italiano
  • Français
  • Português
  • Svenska
  • Nederlands
  • Filter search results
Keywords
Hepatitis C ×
  • Clinical Trial  (125)
  • Eligibility Determination  (69)
  • Gastroenterology  (44)
  • Hepatitis C, Chronic  (2)
  • Hepatitis B  (2)
  • Hepatitis Viruses  (2)
  • HIV  (2)
  • Pregnancy Tests  (1)
  • Rhinitis, Allergic, Perennial  (1)
  • Ribavirin  (1)
  • Serology  (1)
  • Substance Abuse Detection  (1)
  • Urinalysis  (1)
  • Clinical Chemistry Tests  (1)
  • Follicle Stimulating Hormone, Human  (1)
  • Healthy Volunteers  (1)
  • Common Data Elements (CDE)  (1)
  • Trial screening  (1)
  • Released Standard  (1)
  • Estradiol  (1)
  • Glucocorticoids  (1)
Show more Keywords
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
  • Select data models
Selected data models

You must log in to select data models for download or further analysis.

137 Search results.

Sort (Relevance) ▾
  • Relevance
  • Rating
  • New first
  • Old first

RO5024048 in Combination with Pegasys and Copegus in Chronic Hep C NCT01057667 - Eligibility Criteria

- 4/15/19 - 1 form, 2 itemgroups, 9 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Study of RO5024048 in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 1 or 4; ODM derived from: https://clinicaltrials.gov/show/NCT01057667
  • Eligibility Determination
  • Clinical Trial
  • Hepatitis C
  • Hepatitis C, Chronic

Eligibility Hepatitis C Virus NCT02105454

- 4/11/19 - 1 form, 2 itemgroups, 18 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Study of Grazoprevir (MK-5172) + Elbasvir (MK-8742) + Ribavirin in Participants With Chronic Hepatitis C Who Failed Prior Direct-Acting Antiviral Therapy (MK-5172-048); ODM derived from: https://clinicaltrials.gov/show/NCT02105454
  • Eligibility Determination
  • Hepatitis C
  • Gastroenterology
  • Clinical Trial

Eligibility Hepatitis C Virus NCT02023112

- 4/10/19 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT- 267 (ABT-450/r/ABT-267) in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus (HCV) Infection; ODM derived from: https://clinicaltrials.gov/show/NCT02023112
  • Eligibility Determination
  • Hepatitis C
  • Gastroenterology
  • Clinical Trial

Eligibility Hepatitis C Virus Infection NCT02461563

- 4/10/19 - 1 form, 2 itemgroups, 18 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Multiple-Dose Study to Evaluate MK-1075 in Hepatitis C Virus (HCV) Infected Participants (MK-1075-004); ODM derived from: https://clinicaltrials.gov/show/NCT02461563
  • Eligibility Determination
  • Clinical Trial
  • Hepatitis C
  • Gastroenterology

Eligibility Hepatitis C NCT02496078

- 4/10/19 - 1 form, 3 itemgroups, 15 items, 1 language
Itemgroups: Criteria, Inclusion Criteria, Exclusion Criteria
A Phase 3 Evaluation of Daclatasvir and Asunaprevir in Treatment-naive Subjects With Chronic Hepatitis C Genotype 1b Infection; ODM derived from: https://clinicaltrials.gov/show/NCT02496078
  • Eligibility Determination
  • Clinical Trial
  • Gastroenterology
  • Hepatitis C

Eligibility Hepatitis C NCT02455167

- 4/10/19 - 1 form, 2 itemgroups, 24 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Reversal of Hepatic Impairment in Patients With Hepatitis C Virus (HCV) and Early Decompensation of Cirrhosis; ODM derived from: https://clinicaltrials.gov/show/NCT02455167
  • Gastroenterology
  • Hepatitis C
  • Eligibility Determination
  • Clinical Trial

Eligibility Hepatitis C NCT02392494

- 4/10/19 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Evaluation of MK-1075 in Participants With Hepatitis C Virus (HCV) Infection (MK-1075-002); ODM derived from: https://clinicaltrials.gov/show/NCT02392494
  • Gastroenterology
  • Eligibility Determination
  • Hepatitis C
  • Clinical Trial

Eligibility Hepatitis C NCT02214420

- 4/10/19 - 1 form, 2 itemgroups, 24 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
SMV + SOF With/Without RBV for IFN-II Patients With CHC; ODM derived from: https://clinicaltrials.gov/show/NCT02214420
  • Eligibility Determination
  • Clinical Trial
  • Hepatitis C
  • Gastroenterology

Eligibility Hepatitis C NCT02204475

- 4/9/19 - 1 form, 2 itemgroups, 16 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Grazoprevir (MK-5172)/Elbasvir (MK-8742) Versus Boceprevir/Pegylated Interferon/Ribavarin for Chronic Hepatitis C Infection (MK-5172-066); ODM derived from: https://clinicaltrials.gov/show/NCT02204475
  • Eligibility Determination
  • Hepatitis C
  • Clinical Trial
  • Gastroenterology

Eligibility Hepatitis C NCT02203149

- 4/9/19 - 1 form, 2 itemgroups, 17 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Study of Grazoprevir (MK-5172) and Elbasvir (MK-8742) in Japanese Participants With Chronic Hepatitis C (MK-5172-058); ODM derived from: https://clinicaltrials.gov/show/NCT02203149
  • Clinical Trial
  • Gastroenterology
  • Hepatitis C
  • Eligibility Determination

Eligibility Hepatitis C NCT02068963

- 4/9/19 - 1 form, 2 itemgroups, 19 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Collection of Plasma and Serum Samples From Individuals Initiating Sofosbuvir for Chronic Hepatitis C for Testing; ODM derived from: https://clinicaltrials.gov/show/NCT02068963
  • Gastroenterology
  • Eligibility Determination
  • Hepatitis C
  • Clinical Trial

Eligibility Hepatitis C NCT02053519

- 4/9/19 - 1 form, 2 itemgroups, 20 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Can Vitamin D Supplementation Improve Hepatitis C Cure Rates; ODM derived from: https://clinicaltrials.gov/show/NCT02053519
  • Clinical Trial
  • Hepatitis C
  • Gastroenterology
  • Eligibility Determination
  • 1
  • 2 (current)
  • 3
  • 4
  • 5
  • …
  • 12
  • >

Contact

Institute of Medical Informatics
Director: Prof. Dr. Martin Dugas
Albert-Schweitzer-Campus 1, A11
48149 Münster, Germany
Email : imi@uni-muenster.de

In collaboration with

Logo DFG Logo ERCIS Logo IMI Logo ESF Logo ULB Logo IH-D Logo Toolpool Logo EFMI
  • Imprint
  • Disclaimer
  • Data Privacy
© 2019  University of Münster
  • Contact
  • Help
  • Cite

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Login

Forgot password?


Register
Sign in with Certificate